• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物洗脱支架和球囊-材料、结构设计和涂层技术:综述。

Drug-Eluting Stents and Balloons-Materials, Structure Designs, and Coating Techniques: A Review.

机构信息

Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, 61-614 Poznań, Poland.

Eye Department, J. Strus City Hospital, Szwajcarska 3, 61-285 Poznań, Poland.

出版信息

Molecules. 2020 Oct 11;25(20):4624. doi: 10.3390/molecules25204624.

DOI:10.3390/molecules25204624
PMID:33050663
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7594099/
Abstract

Controlled drug delivery is a matter of interest to numerous scientists from various domains, as well as an essential issue for society as a whole. In the treatment of many diseases, it is crucial to control the dosing of a drug for a long time and thus maintain its optimal concentration in the tissue. Heart diseases are particularly important in this aspect. One such disease is an obstructive arterial disease affecting millions of people around the world. In recent years, stents and balloon catheters have reached a significant position in the treatment of this condition. Balloon catheters are also successfully used to manage tear ducts, paranasal sinuses, or salivary glands disorders. Modern technology is continually striving to improve the results of previous generations of stents and balloon catheters by refining their design, structure, and constituent materials. These advances result in the development of both successive models of drug-eluting stents (DES) and drug-eluting balloons (DEB). This paper presents milestones in the development of DES and DEB, which are a significant option in the treatment of coronary artery diseases. This report reviews the works related to achievements in construction designs and materials, as well as preparation technologies, of DES and DEB. Special attention was paid to the polymeric biodegradable materials used in the production of the above-mentioned devices. Information was also collected on the various methods of producing drug release coatings and their effectiveness in releasing the active substance.

摘要

控释药物输送是众多来自不同领域的科学家感兴趣的问题,也是整个社会的一个重要问题。在治疗许多疾病时,控制药物的长时间剂量以保持其在组织中的最佳浓度至关重要。心脏病在这方面尤为重要。其中一种疾病是影响全球数百万人的阻塞性动脉疾病。近年来,支架和球囊导管在治疗这种疾病方面取得了显著地位。球囊导管也成功用于治疗泪管、副鼻窦或唾液腺疾病。现代技术不断努力通过改进支架和球囊导管的设计、结构和组成材料来提高前几代的治疗效果。这些进步导致了药物洗脱支架(DES)和药物洗脱球囊(DEB)的连续模型的发展。本文介绍了 DES 和 DEB 的发展里程碑,它们是治疗冠状动脉疾病的重要选择。本报告回顾了与 DES 和 DEB 的构建设计和材料以及制备技术相关的工作。特别关注用于生产上述装置的可生物降解的聚合物材料。还收集了关于生产药物释放涂层的各种方法及其释放活性物质的有效性的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/eb54b6aaa7a4/molecules-25-04624-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/dabf1b070501/molecules-25-04624-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/0a3de78c8fa4/molecules-25-04624-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/044767919927/molecules-25-04624-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/45a2e2422a4e/molecules-25-04624-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/815375c9dfe1/molecules-25-04624-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/6475ed66a9a0/molecules-25-04624-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/a41662b3898e/molecules-25-04624-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/cd1aab4d67f9/molecules-25-04624-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/eb54b6aaa7a4/molecules-25-04624-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/dabf1b070501/molecules-25-04624-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/0a3de78c8fa4/molecules-25-04624-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/044767919927/molecules-25-04624-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/45a2e2422a4e/molecules-25-04624-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/815375c9dfe1/molecules-25-04624-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/6475ed66a9a0/molecules-25-04624-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/a41662b3898e/molecules-25-04624-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/cd1aab4d67f9/molecules-25-04624-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0def/7594099/eb54b6aaa7a4/molecules-25-04624-g009.jpg

相似文献

1
Drug-Eluting Stents and Balloons-Materials, Structure Designs, and Coating Techniques: A Review.药物洗脱支架和球囊-材料、结构设计和涂层技术:综述。
Molecules. 2020 Oct 11;25(20):4624. doi: 10.3390/molecules25204624.
2
The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.单纯药物球囊或与药物洗脱支架联合治疗初发型弥漫性冠状动脉疾病的作用。
JACC Cardiovasc Interv. 2013 Nov;6(11):1153-9. doi: 10.1016/j.jcin.2013.07.005.
3
Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.药物洗脱球囊、药物洗脱支架与普通球囊血管成形术治疗支架内再狭窄的比较:11 项随机对照试验的网络荟萃分析。
JACC Cardiovasc Interv. 2015 Mar;8(3):382-394. doi: 10.1016/j.jcin.2014.09.023. Epub 2015 Feb 18.
4
Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.药物洗脱支架再狭窄的治疗:一项回顾性观察研究中药物洗脱球囊与第二代药物洗脱支架的比较
Catheter Cardiovasc Interv. 2016 Oct;88(4):522-528. doi: 10.1002/ccd.26368. Epub 2015 Dec 30.
5
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.3 年 RIBS IV 临床试验临床随访:药物洗脱球囊与依维莫司洗脱支架治疗药物洗脱支架治疗后冠状动脉支架内再狭窄患者的前瞻性随机研究。
JACC Cardiovasc Interv. 2018 May 28;11(10):981-991. doi: 10.1016/j.jcin.2018.02.037.
6
In-stent restenosis: the gold standard has changed.支架内再狭窄:金标准已改变。
EuroIntervention. 2011 May;7 Suppl K:K43-6. doi: 10.4244/EIJV7SKA7.
7
Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.药物洗脱球囊治疗后行血管内影像学分析与药物洗脱支架治疗初发病变的比较。
Korean J Intern Med. 2019 Jul;34(4):819-829. doi: 10.3904/kjim.2017.378. Epub 2018 Jul 4.
8
The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.与药物洗脱支架及传统球囊血管成形术相比,药物洗脱球囊治疗支架内再狭窄的疗效和安全性。
Korean J Intern Med. 2016 May;31(3):501-6. doi: 10.3904/kjim.2014.189. Epub 2015 Dec 21.
9
Long-term outcomes following drug-eluting balloons vs. thin-strut drug-eluting stents for treatment of recurrent restenosis in drug-eluting stents.药物洗脱球囊与薄支柱药物洗脱支架治疗药物洗脱支架内再狭窄的长期预后
Kardiol Pol. 2022;80(7-8):765-773. doi: 10.33963/KP.a2022.0106. Epub 2022 Apr 21.
10
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials.药物洗脱球囊与药物洗脱支架治疗冠状动脉疾病的比较:一项随机对照试验的荟萃分析
BMC Cardiovasc Disord. 2018 Mar 2;18(1):46. doi: 10.1186/s12872-018-0771-y.

引用本文的文献

1
Biodegradable Contact Lenses for Targeted Ocular Drug Delivery: Recent Advances, Clinical Applications, and Translational Perspectives.用于靶向眼部药物递送的可生物降解隐形眼镜:最新进展、临床应用及转化前景
Molecules. 2025 Jun 10;30(12):2542. doi: 10.3390/molecules30122542.
2
Drug-Coated Balloons vs. Plain Balloon Angioplasty for Side Branch Management in Coronary Bifurcation Lesions: A Systematic Review and Meta-Analysis.药物涂层球囊与普通球囊血管成形术用于冠状动脉分叉病变分支处理的系统评价与Meta分析
Anatol J Cardiol. 2025 May 23;29(6):272-9. doi: 10.14744/AnatolJCardiol.2025.5296.
3
Drug coated balloons in percutaneous coronary intervention: how can computational modelling help inform evolving clinical practice?

本文引用的文献

1
Poly-Lactic Acid: Production, Applications, Nanocomposites, and Release Studies.聚乳酸:生产、应用、纳米复合材料及释放研究
Compr Rev Food Sci Food Saf. 2010 Sep;9(5):552-571. doi: 10.1111/j.1541-4337.2010.00126.x.
2
Comparison Study on Four Biodegradable Polymer Coatings for Controlling Magnesium Degradation and Human Endothelial Cell Adhesion and Spreading.四种用于控制镁降解以及人类内皮细胞黏附与铺展的可生物降解聚合物涂层的比较研究
ACS Biomater Sci Eng. 2017 Jun 12;3(6):936-950. doi: 10.1021/acsbiomaterials.7b00215. Epub 2017 May 17.
3
A novel biodegradable and biologically functional arginine-based poly(ester urea urethane) coating for Mg-Zn-Y-Nd alloy: enhancement in corrosion resistance and biocompatibility.
经皮冠状动脉介入治疗中的药物涂层球囊:计算模型如何助力优化临床实践?
Front Med Technol. 2025 Apr 30;7:1546417. doi: 10.3389/fmedt.2025.1546417. eCollection 2025.
4
Trials of a drug release platform in near-spherical porous NiTi alloys containing a thermosensitive hydrogel as the inner coating.在含有热敏水凝胶作为内涂层的近球形多孔镍钛合金中进行药物释放平台的试验。
RSC Adv. 2025 May 12;15(20):15639-15650. doi: 10.1039/d5ra01925g.
5
Paclitaxel-coated balloon catheter versus paclitaxel-eluting stent for the treatment of coronary in-stent restenosis: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials.紫杉醇涂层球囊导管与紫杉醇洗脱支架治疗冠状动脉支架内再狭窄的比较:一项GRADE评估的随机对照试验系统评价和荟萃分析
Medicine (Baltimore). 2025 Apr 11;104(15):e42113. doi: 10.1097/MD.0000000000042113.
6
The Impact of Peripheral Vascular Motion on Acute Drug Retention of Intravascular Devices.外周血管运动对血管内装置急性药物滞留的影响
Cardiovasc Eng Technol. 2025 Feb 13. doi: 10.1007/s13239-025-00776-z.
7
Moving away from metal: Step toward the future with bioresorbable vascular scaffolds and novel antiproliferative agents.告别金属:借助生物可吸收血管支架和新型抗增殖药物迈向未来。
JVS Vasc Sci. 2024 Dec 18;6:100277. doi: 10.1016/j.jvssci.2024.100277. eCollection 2025.
8
Learning-based distortion correction enables proximal-scanning endoscopic OCT elastography.基于学习的畸变校正实现了近端扫描内镜光学相干断层扫描弹性成像。
Biomed Opt Express. 2024 Jun 26;15(7):4345-4364. doi: 10.1364/BOE.528522. eCollection 2024 Jul 1.
9
Laplace Transform Based Modeling of Drug Delivery with Reversible Drug Binding in a Multilayer Tissue.基于拉普拉斯变换的多层组织中可逆药物结合的药物传递建模。
Pharm Res. 2024 Jun;41(6):1093-1107. doi: 10.1007/s11095-024-03711-4. Epub 2024 Jun 11.
10
Systematic Review on Role of Drug Eluting Stent (DES) Versus Drug-Coated Balloon (DCB) in Small Vessel Coronary Artery Disease.系统评价:药物洗脱支架(DES)与药物涂层球囊(DCB)在小血管冠状动脉疾病中的作用
Curr Cardiol Rep. 2024 Jul;26(7):681-688. doi: 10.1007/s11886-024-02077-8. Epub 2024 Jun 8.
一种用于镁锌钇钕合金的新型可生物降解且具有生物功能的基于精氨酸的聚(酯脲聚氨酯)涂层:耐腐蚀性和生物相容性的增强
J Mater Chem B. 2017 Mar 7;5(9):1787-1802. doi: 10.1039/c6tb03147a. Epub 2017 Feb 15.
4
Nanofibrous vildagliptin-eluting stents enhance re-endothelialization and reduce neointimal formation in diabetes: in vitro and in vivo.纳米纤维伏格列汀洗脱支架增强糖尿病患者血管再内皮化和减少新生内膜形成:体内外研究。
Int J Nanomedicine. 2019 Sep 13;14:7503-7513. doi: 10.2147/IJN.S211898. eCollection 2019.
5
Nanomatrix Coated Stent Enhances Endothelialization but Reduces Platelet, Smooth Muscle Cell, and Monocyte Adhesion under Physiologic Conditions.纳米基质涂层支架可增强内皮化,但在生理条件下可减少血小板、平滑肌细胞和单核细胞的黏附。
ACS Biomater Sci Eng. 2018 Jan 8;4(1):107-115. doi: 10.1021/acsbiomaterials.7b00676. Epub 2017 Nov 28.
6
Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems.聚乳酸(PLA)在医用植入物和诊疗系统中的生物相容性、生物降解性及排泄情况。
Chem Eng J. 2018 May 15;340:9-14. doi: 10.1016/j.cej.2018.01.010. Epub 2018 Jan 3.
7
Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review.药物洗脱支架再狭窄:基于发病机制的新分类系统指导治疗及最新研究综述。
Circ Cardiovasc Interv. 2019 Aug;12(8):e007023. doi: 10.1161/CIRCINTERVENTIONS.118.007023. Epub 2019 Jul 26.
8
Coating Techniques and Release Kinetics of Drug-Eluting Stents.药物洗脱支架的涂层技术与释放动力学
J Med Device. 2019 May 4;10(1). doi: 10.1115/1.4031718. Epub 2015 Nov 5.
9
Meta-analysis of the effects of drug-coated balloons among patients with small-vessel coronary artery disease.药物涂层球囊对小血管冠状动脉疾病患者影响的荟萃分析。
Medicine (Baltimore). 2019 May;98(22):e15797. doi: 10.1097/MD.0000000000015797.
10
Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease.药物涂层球囊血管成形术与普通球囊血管成形术治疗股腘动脉疾病的系统评价和更新的荟萃分析。
J Vasc Surg. 2019 Sep;70(3):981-995.e10. doi: 10.1016/j.jvs.2019.01.080. Epub 2019 May 21.